Grafted semiconductors on PE-films leading to bacterial inactivation: Synthesis, characterization and mechanism

This study reports the colloidal preparation FeOx, TiO2 and FeOx-TiO2 grafted on polyethylene (PE) films leading to bacterial inactivation. A fast bacterial inactivation was attained by the FeOx-TiO2 compared to the FeOx-PE film due to the interfacial charge transfer (IFCT) FeOx to the lower-lying TiO2 trapped states. A pH-decrease was observed during bacterial inactivation due to the formation of carboxylic acids on the grafted films and the recovery to the initial pH 7 after elimination of the intermediates was followed quantitatively during bacterial inactivation. The potential on the TiO2-PE, FeOx-PE and FeOx-TiO2-PE film surfaces decreased during the bacterial inactivation concomitant with the loss of the cell wall permeability. Different mechanisms for the photo-induced E. coil inactivation for random nanoparticulate FeOx-PE and FeOx-TiO2-PE films are suggested based on the experimental observations reported in this study. During the inactivation of E. coli, the Fe-ions were seen to leach out in amounts <= 0.45 ppm. This is within the EU sanitary allowed limits for industrial/drinking water. The wettability of the films was followed by contact angle measurements (CA) within the time of bacterial inactivation. By diffuse reflectance spectroscopy (DRS), the conversion of the Fe(III)-oxide to Fe(II)-oxide is reported during film recycling. The change in the Fe-oxidation states within the bacterial inactivation was further confirmed by X-ray photoelectron spectroscopy (XPS). (C) 2016 Elsevier B.V. All rights reserved

Coupling of narrow and wide band-gap semiconductors on uniform films active in bacterial disinfection under low intensity visible light: Implications of the interfacial charge transfer (IFCT)

This study reports the design, preparation, testing and surface characterization of uniform films deposited by sputtering Ag and Ta on non-heat resistant polyester to evaluate the Escherichia coil inactivation by TaON, TaN/Ag, Ag and TaON/Ag polyester. Co-sputtering for 120 s Ta and Ag in the presence of N-2 and O-2 led to the faster E. coil inactivation by a TaON/Ag sample within similar to 40 min under visible light irradiation. The deconvolution of TaON/Ag peaks obtained by X-ray photoelectron spectroscopy (XPS) allowed the assignment of the Ta2O5 and Ag-species. The shifts observed for the XPS peaks have been assigned to Ago to Ag2O and Ag-0, and are a function of the applied sputtering times. The mechanism of interfacial charge transfer (IFCT) from the Ag2O conduction band (cb) to the lower laying Ta2O5 (cb) is discussed suggesting a reaction mechanism. The optical absorption of the TaON and TaON/Ag samples found by diffuse reflectance spectroscopy (DRS) correlated well with the kinetics of E. coli inactivation. The TaON/Ag sample microstructure was characterized by contact angle (CA) and by atomic force microscopy (AFM). Self-cleaning of the TaON/Ag polyester after each disinfection cycle enabled repetitive E. coil inactivation. (C) 2013 Elsevier B.V. All rights reserved

Occult Hepatitis B Infection in Patients With Cryptogenic Liver Cirrhosis in Southwest of Iran

Background: Chronic hepatitis B virus (HBV) infection has a broad spectrum of manifestation, ranging from silent carrier state to advanced cirrhosis and hepatocellular carcinoma. The persistence of HBV DNA in serum and hepatocytes of the cirrhotic patient could be detected by molecular techniques in spite of negative HBV serologic markers. Objectives: This case-control study was designed to evaluate the prevalence of occult HBV infection (OBI) in patients with cryptogenic liver cirrhosis in comparison with healthy subjects. Patients and Methods: Of 165 patients with liver cirrhosis, 50 consecutive patients with cryptogenic cirrhosis and 80 healthy individual without any risk factors as a control group were enrolled in this study. Their sera were tested for HBV DNA using nested PCR method. Results: Of 50 patients with cryptogenic cirrhotic, 36 (72%) were male. The mean age of patients was 53.34 ± 14.73 years; 80 healthy subjects were selected as control group with mean age of 32.65 ± 8.51 years; 7 (14%) of the patients with cryptogenic cirrhosis showed positive HBV DNA by PCR, while HBV DNA was negative for the control group (P = 0.0001); 4 (57%) cases with positive HBV shown by PCR were negative for anti-HBc and anti-HBs tests. The mean level of transaminases was significantly higher in patients with cirrhosis. There were no significant differences in demographic parameters, transaminases level and degree of hepatic failure among cirrhotic patients with and without OBI. Conclusions: The prevalence of OBI was relatively high in patients with cryptogenic cirrhosis. OBI was found among the patients above 40 years old. Prospective cohort studies are needed to evaluate the clinical significance of OBI

Comparing HBV Viral Load in Serum, Cerumen, and Saliva and Correlation With HBeAg Serum Status in Patients With Chronic Hepatitis B Infection

Background: Hepatitis B is a disease that is prevalent worldwide and is responsible for 10 of the deaths that occur every year. The virus persists in 5 of infected adults and 90 of infected children and can cause chronic hepatitis. In addition to blood, the virus may also be present in other secretions. Transmission through saliva, sexual fluids, and urine has also been confirmed. Objectives: The main aim of this study was to compare viral DNA copies in the serum, cerumen, and saliva of patients with HBeAg levels in their sera. Patients and Methods: This was a cross-sectional study and subjects were selected by non-randomized methods. Serum, cerumen, and saliva samples were collected from 50 patients who were diagnosed with chronic hepatitis B about a year prior to the study. Enzyme-linked immunosorbent assay (ELISA) was performed to determine the presence of HBsAg and HBeAg in the gathered specimens. Viral DNA was extracted from specimens by using a Qiagen kit. The number of viral DNA copies was determined using a real-time polymerase chain reaction (PCR) assay. The study was performed in Ilam province in western Iran. Results: Twenty-eight percent of the patients were HBeAg positive. The average number of viral copies in serum, cerumen, and saliva was higher in women than in men, and a significant correlation was observed between the gender and average viral copies. However, no significant correlation was observed between viral copies present in the serum and cerumen with the age and gender of patients. In addition, no correlation was observed between serum HBeAg and viral copies present in serum, cerumen, and saliva. The correlation analysis confirmed a direct and definite correlation between viral DNA loads in the patients' serum and cerumen. Conclusions: A significant direct correlation was observed between the viral DNA copies present in patients' cerumen and serum. However, the correlation between saliva viral load with serum and cerumen viral load was very low and inverse. These findings suggest that the presence of the hepatitis B virus (HBV) in non-invasive specimens (such as cerumen and saliva) should also be evaluated when monitoring patients to determine the course of infection and disease

ZrNO-Ag co-sputtered surfaces leading to E. coli inactivation under actinic light: Evidence for the oligodynamic effect

This study reports visible light sensitive ZrNO and ZrNO-Ag polyester samples prepared by sputtering in an Ar/N-2/O-2 atmosphere leading to Escherichia coil bacterial inactivation. The bacterial inactivation by ZrNO avoids the increasing environmental concern involving the fate of Ag-leaching of many disinfectants. The simultaneous co-sputtering of ZrNO and Ag2O enhanced the E. coli bacterial inactivation kinetics compared to the sequential sputtering of ZrNO and Ag. A reaction mechanism is suggested triggered by photoinduced interfacial charge transfer (IFCT) suggesting electron injection form the Ag2Ocb, to the ZrO2cb. The sizes of the ZrO2 and Ag nanoparticles in the co-sputtered ZrNO-Ag were 80-130 nm and 8-15 nm respectively as determined by high angular annular dark field (HAADF) microscopy. Evidence is presented by X-ray photoelectron spectroscopy (XPS) for the self-cleaning of the photocatalysts after bacterial inactivation. This enabled a stable catalyst reuse. The XPS experimental spectra of ZrNO and ZrNO-Ag were deconvoluted into their ZrN, ZrNO and ZrO2 components. The amounts of Ag-ions released during bacterial inactivation were <5 ppb/cm(2) and well below the Ag cytotoxic levels. Since no cytotoxicity was introduced during the bacterial inactivation process, the ZrNO-Ag disinfection proceeds through an oligodynamic effect. (C) 2013 Elsevier B.V. All rights reserved

Photocatalysis/catalysis by innovative TiN and TiN-Ag surfaces inactivate bacteria under visible light

This study presents the design, preparation, testing and characterization of TiN and TiN-Ag nanoparticulate films leading to photocatalytic and catalytic inactivation of Escherichia coli. When Ti was sputtered in N2 atmosphere, the TiN films unexpectedly revealed semiconductor properties when irradiated under visible light due to the formation of TiO2 showing absorption in the visible spectral region. In TiN-Ag films, Ag enhances the photocatalytic activity of TiN leading to faster bacterial inactivation. Evidence for the presence of TiO2 and TiN in the films is presented by XPS. The TiN layers 50 nm thick sputtered by DC for 3 min led to complete inactivation of E. coli within 120 min. But TiN layers with a thickness >50 nm hinder the surface diffusion of charges reducing bacterial inactivation. The rate of TiN deposition was ∼1.4 ×1015 atoms TiN/cm2s. For the TiN-polyester samples under visible light a 3 log10 bacterial reduction (99.9%) was observed within 30 min while for TiN-Ag samples the same bacterial reduction was attained within ∼15 min. The absorption of the TiN-Ag samples in Kubelka–Munk (KM) units was directly proportional to the E. coli inactivation kinetics. TiN-Ag plasmon nanostructures are concurrently formed under low intensity visible light and accelerated bacterial inactivation. This study shows that TiN films have the potential to replace Ag-based disinfection materials leaching Ag into the environment

Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort

Background Liver function tests (LFTs) are ordered in large numbers in primary care, and the Birmingham and Lambeth Liver Evaluation Testing Strategies (BALLETS) study was set up to assess their usefulness in patients with no pre-existing or self-evident liver disease. All patients were tested for chronic viral hepatitis thereby providing an opportunity to compare various strategies for detection of this serious treatable disease. Methods This study uses data from the BALLETS cohort to compare various testing strategies for viral hepatitis in patients who had received an abnormal LFT result. The aim was to inform a strategy for identification of patients with chronic viral hepatitis. We used a cost-minimisation analysis to define a base case and then calculated the incremental cost per case detected to inform a strategy that could guide testing for chronic viral hepatitis. Results Of the 1,236 study patients with an abnormal LFT, 13 had chronic viral hepatitis (nine hepatitis B and four hepatitis C). The strategy advocated by the current guidelines (repeating the LFT with a view to testing for specific disease if it remained abnormal) was less efficient (more expensive per case detected) than a simple policy of testing all patients for viral hepatitis without repeating LFTs. A more selective strategy of viral testing all patients for viral hepatitis if they were born in countries where viral hepatitis was prevalent provided high efficiency with little loss of sensitivity. A notably high alanine aminotransferase (ALT) level (greater than twice the upper limit of normal) on the initial ALT test had high predictive value, but was insensitive, missing half the cases of viral infection. Conclusions Based on this analysis and on widely accepted clinical principles, a "fast and frugal" heuristic was produced to guide general practitioners with respect to diagnosing cases of viral hepatitis in asymptomatic patients with abnormal LFTs. It recommends testing all patients where a clear clinical indication of infection is present (e.g. evidence of intravenous drug use), followed by testing all patients who originated from countries where viral hepatitis is prevalent, and finally testing those who have a notably raised ALT level (more than twice the upper limit of normal). Patients not picked up by this efficient algorithm had a risk of chronic viral hepatitis that is lower than the general population

Bidirectional lipid droplet velocities are controlled by differential binding strengths of HCV Core DII protein

Host cell lipid droplets (LD) are essential in the hepatitis C virus (HCV) life cycle and are targeted by the viral capsid core protein. Core-coated LDs accumulate in the perinuclear region and facilitate viral particle assembly, but it is unclear how mobility of these LDs is directed by core. Herein we used two-photon fluorescence, differential interference contrast imaging, and coherent anti-Stokes Raman scattering microscopies, to reveal novel core-mediated changes to LD dynamics. Expression of core protein’s lipid binding domain II (DII-core) induced slower LD speeds, but did not affect directionality of movement on microtubules. Modulating the LD binding strength of DII-core further impacted LD mobility, revealing the temporal effects of LD-bound DII-core. These results for DII-core coated LDs support a model for core-mediated LD localization that involves core slowing down the rate of movement of LDs until localization at the perinuclear region is accomplished where LD movement ceases. The guided localization of LDs by HCV core protein not only is essential to the viral life cycle but also poses an interesting target for the development of antiviral strategies against HCV

Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis

Testing for hepatitis C virus (HCV) infection may reduce the risk of liver-related morbidity, by facilitating earlier access to treatment and care. This review investigated the effectiveness of targeted testing interventions on HCV case detection, treatment uptake, and prevention of liver-related morbidity. A literature search identified studies published up to 2013 that compared a targeted HCV testing intervention (targeting individuals or groups at increased risk of HCV) with no targeted intervention, and results were synthesised using meta-analysis. Exposure to a targeted testing intervention, compared to no targeted intervention, was associated with increased cases detected [number of studies (n) = 14; pooled relative risk (RR) 1.7, 95 % CI 1.3, 2.2] and patients commencing therapy (n = 4; RR 3.3, 95 % CI 1.1, 10.0). Practitioner-based interventions increased test uptake and cases detected (n = 12; RR 3.5, 95 % CI 2.5, 4.8; and n = 10; RR 2.2, 95 % CI 1.4, 3.5, respectively), whereas media/information-based interventions were less effective (n = 4; RR 1.5, 95 % CI 0.7, 3.0; and n = 4; RR 1.3, 95 % CI 1.0, 1.6, respectively). This meta-analysis provides for the first time a quantitative assessment of targeted HCV testing interventions, demonstrating that these strategies were effective in diagnosing cases and increasing treatment uptake. Strategies involving practitioner-based interventions yielded the most favourable outcomes. It is recommended that testing should be targeted at and offered to individuals who are part of a population with high HCV prevalence, or who have a history of HCV risk behaviour